Table 3.
Adjusted Multivariate Conditional Logistic Regression Analysis of the Potential Risk Factors for Post-Sustained Virologic Response Hepatocellular Carcinoma
| Variable | AOR (95% CI) | B | p-value |
|---|---|---|---|
| Initial diagnostic stage | |||
| Chronic hepatitis C | 1.0 (reference) | NA | NA |
| Compensated liver cirrhosis | 21.7 (4.2–112.3) | 3.1 | <0.001 |
| Post-SVR albumin (by every 1 g/L increase) | 0.8 (0.6–0.9) | −0.3 | 0.004 |
| Antivirals-administered disease stage | |||
| Chronic hepatitis C | 1.0 (reference) | NA | NA |
| Compensated liver cirrhosis | NA | NA | 0.113 |
| Post-SVR AFP (by every 1 ng/mL increase) | NA | NA | 0.196 |
AOR, adjusted odds ratios; CI, confidence interval; B, regression coefficient; NA, not applicable; SVR, sustained virologic response; AFP, α-fetoprotein.